3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
3
Esophageal Squamous Cell Carcinoma
2
Pathologic Complete Response
1
Adenocarcinoma Of Esophagus
1
Interventions
Oxaliplatin
3
Fluorouracil
3
Radiotherapy
2
Immune Checkpoint Inhibitors
2
Endoscopy
2
Drug Therapy
2
Chemoradiotherapy
2
toripalimab
1
tislelizumab
1
pembrolizumab
1
X-Rays
1
Tretinoin
1
TP protocol
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Proctectomy
1
Positron Emission Tomography Computed Tomography
1
Neoadjuvant Therapy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Immunotherapy
1
Immunohistochemistry
1
Esophagectomy
1
Epirubicin
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Docetaxel
1
Diffusion Magnetic Resonance Imaging
1
Cisplatin
1
Capecitabine
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Diffusion Magnetic Resonance Imaging
×
Gastrointestinal
×
Clear all
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled